![]() |
Case Report
1 Centre Régional de Transfusion Sanguine, Avenue Errazi, Oujda 60000, Morocco
2 Centre National de Transfusion Sanguine et d’hématologie, 472, rue Mfadel Cherkaoui, q. Al Irfane, Rabat, Morocco
Address correspondence to:
Saliha Mharchi
Centre Régional de Transfusion Sanguine, Avenue Errazi, Oujda 60000,
Morocco
Message to Corresponding Author
Article ID: 100057Z02SM2021
At the end of March 2020, the new coronavirus disease (COVID-19) caused by the SARS-CoV-2 virus was declared a global pandemic. By mid-May, the number of confirmed cases had risen to more than 5 million and more than 300,000 deaths were reported worldwide. Morocco confirmed its first imported case of COVID-19 on March 2, 2020. As of May 31, 2020, there were 7550 confirmed cases of infection with this virus. Like many countries, this epidemic prompted the Moroccan government, as of 20 March 2020, to apply travel restrictions and suspend travel within and between cities to prevent the spread of the disease. These distancing measures have resulted in effective control of the virus. However, they also have a profound effect on the health system, relatively speaking, on blood donation and supply and the management of transfusion at the national level. In this context, on March 20, 2020, WHO provided guidance on the management of the blood supply. In addition, the National Centre for Blood Transfusion and Haematology (NCBTH) has accompanied the Regional Centers for Blood Transfusion (RCBT) of the kingdom through the implementation of a new strategy to deal with a possible shortage of blood supply. In response to such a situation, the Oujda Regional Center for Blood Transfusion (ORCBT) anticipated the development of a proactive regional strategy in collaboration with the Blood Donor Association of the Eastern Region (BDAER), and set up accompanying measures during the pandemic. The objective of this study is to describe the strategies undertaken during the COVID-19 pandemic and their impact on all transfusion activities from blood collection, delivery, and transfusion of Labile Blood Products (LBPs). To achieve our objective, we performed a comparative prospective analytical study from January 1 to May 31 of 2019 and 2020 years at the ORCBT, located in the prefecture of Oujda Angad. The results of this study showed a positive impact, to some extent, of the strategies implemented, first on blood collection and then on the center′s safety stock, which remained at the same level despite the containment circumstances. Thus, the ORCBT carried out its mission by responding to the majority of requests for LBPs that were addressed to it with a satisfaction rate of over 90% for all health facilities in the eastern region during the study period.
Keywords: Blood demand, Blood donation, Blood transfusion, COVID-19, Eastern region, Label Blood Product
We salute the efforts of all health care workers and especially the personnel of ORCBT during this pandemic. We warmly thank all the donors and BDAER who helped us to overcome this crisis.
Author ContributionsSaliha Mharchi - Conception of the work, Design of the work, Acquisition of data, Analysis of data, Drafting the work, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Mounir Cherfi - Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Ahmed Karim - Acquisition of data, Analysis of data, Drafting the work, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Abdelhamid Bouazza - Acquisition of data, Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Zaina Sidqi - Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Mohammed Benajiba - Revising the work critically for important intellectual content, Final approval of the version to be published, Agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Guarantor of SubmissionThe corresponding author is the guarantor of submission.
Source of SupportNone
Consent StatementWritten informed consent was obtained from the patient for publication of this article.
Data AvailabilityAll relevant data are within the paper and its Supporting Information files.
Conflict of InterestAuthors declare no conflict of interest.
Copyright© 2021 Saliha Mharchi et al. This article is distributed under the terms of Creative Commons Attribution License which permits unrestricted use, distribution and reproduction in any medium provided the original author(s) and original publisher are properly credited. Please see the copyright policy on the journal website for more information.